Can we harness our immune system to fight NSCLC?

Can we harness our immune system to fight NSCLC?

Da: GRACEcast
0 0 7 anni fa
Drs. Mary Pinder, Nate Pennell, and Jack West discuss promising work on immune checkpoint inhibitors such as MPPL-3280A, an anti-PDL1 immune-based therapy, and anti-PD1 therapy nivolumab, in advanced NSCLC.

Seguici su Facebook